TargetMol

Esaprazole

Product Code:
 
TAR-T31675
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31675-5mg5mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31675-1mL1 mL * 10 mM (in DMSO)£116.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31675-10mg10mg£131.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31675-25mg25mg£173.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31675-50mg50mg£225.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31675-100mg100mg£301.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31675-200mg200mg£417.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31675-500mg500mg£643.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Esaprazole has a dose - dependent cellular protective effect on the human gastric mucosa.
CAS:
64204-55-3
Formula:
C12H23N3O
Molecular Weight:
225.336
Purity:
0.95
SMILES:
O=C(CN1CCNCC1)NC1CCCCC1

References

1. Ardizzone S, Sangaletti O, Ghirardosi C, Bianchi Porro G. Effect of esaprazole on gastric mucosal potential difference after oral administration of aspirin (ASA). J Int Med Res. 1986;14(6):321- 2. Dal Santo PL, Vianello F, Germana B, Dotto P, Laino G, Del Bianco T, Plebani M, Leandro G, Savarino V, Di Mario F. Esaprazole effect on acid, peptic and alkaline secretion in duodenal ulcer patients. Z Gastroenterol. 1993 Jan;31(1):11-PubMed PMID: 8447149. 3. Blandizzi C, Mengozzi G, Intorre L, Natale G, Soldani G, Del Tacca M. Inhibitory cholinergic effects of esaprazole on gastric secretion and plasma gastrin levels in the dog. Pharmacology. 1993 Apr;46(4):231-40. PubMed PMID: 8483969. 4. Blandizzi C, Natale G, De Bona M, Del Tacca M. Gastric antisecretory effects of esaprazole in rats. Digestion. 1992;51(4):226-3PubMed PMID: 1356865.